Q9HCH5 (SYTL2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 97.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Synaptotagmin-like protein 2 Alternative name(s): Breast cancer-associated antigen SGA-72M Exophilin-4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 934 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Isoform 1 acts as a RAB27A effector protein and plays a role in cytotoxic granule exocytosis in lymphocytes. It is required for cytotoxic granule docking at the immunologic synapse. Isoform 4 binds phosphatidylserine (PS) and phosphatidylinositol-4,5-bisphosphate (PIP2) and promotes the recruitment of glucagon-containing granules to the cell membrane in pancreatic alpha cells. Binding to PS is inhibited by Ca2+ while binding to PIP2 is Ca2+ insensitive. Ref.1 Ref.9 Ref.10 |
| Subunit structure | Monomer. Binds NRXN1. Interacts with RAB27B By similarity. Binds RAB27A that has been activated by GTP-binding. Ref.1 Ref.11 |
| Subcellular location | Isoform 1: Cytoplasm. Cell membrane. Note: Recruited on vesicular structures in cytotoxic T-lymphocytes (CTL) by RAB27A. Ref.1 Ref.9 Ref.10 Isoform 4: Cell membrane. Note: In the pancreatic alpha cells distributed in both peripheral and anterior regions. Localizes on the glucagon granules in the cell periphery. Ref.1 Ref.9 Ref.10 |
| Tissue specificity | Isoform 1 is expressed in hematopoietic lineages with a strong expression in CD4 and CD8 T-lymphocytes. It is also widely expressed in nonhematopoietic tissues. Isoform 5 is expressed only in nonhematopoietic tissues. Isoform 4 is expressed in pancreatic alpha cells. Ref.1 Ref.9 Ref.10 |
| Domain | The RabBD domain mediates interaction with RAB27A and recruitment on to vesicular structures in cytotoxic T-lymphocytes (CTL). Ref.1 Ref.9 The C2 1 domain mediates binding to phosphatidylserine (PS) and phosphatidylinositol-4,5-bisphosphate (PIP2) and localization to the cell membrane. Ref.1 Ref.9 |
| Post-translational modification | Isoform 1 is highly susceptible to proteolytic degradation and is stabilized by the interaction with RAB27A. |
| Sequence similarities | Contains 2 C2 domains. Contains 1 RabBD (Rab-binding) domain. |
| Sequence caution | The sequence AAR25619.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence BAA90989.1 differs from that shown. Reason: Probable cloning artifact. The sequence BAB13423.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAB13423.1 differs from that shown. Reason: Frameshift at position 13. The sequence BAB13423.1 differs from that shown. Reason: Sequencing errors. The sequence BAD18516.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Alternative products
| This entry describes 12 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9HCH5-1) Also known as: Hematopoietic form of Slp2a; Slp2a-hem; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9HCH5-2) The sequence of this isoform differs from the canonical sequence as follows: 1-558: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q9HCH5-4) The sequence of this isoform differs from the canonical sequence as follows: 1-558: Missing. 571-610: Missing. | ||||||
| Isoform 4 (identifier: Q9HCH5-6) The sequence of this isoform differs from the canonical sequence as follows: 539-539: V → DEKPDQKPVTNECVPRI 571-610: Missing. | ||||||
| Isoform 5 (identifier: Q9HCH5-7) The sequence of this isoform differs from the canonical sequence as follows: 1-487: MIDLSFLTEE...GGSSRDRQQG → MDEPNAEQVY...NAESWRNPSS | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 6 (identifier: Q9HCH5-8) The sequence of this isoform differs from the canonical sequence as follows: 1-487: MIDLSFLTEE...GGSSRDRQQG → MDEPNAEQVY...NAESWRNPSS 539-539: V → DEKPDQKPVTNECVPRI | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 7 (identifier: Q9HCH5-9) The sequence of this isoform differs from the canonical sequence as follows: 1-569: Missing. 570-570: E → M | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 8 (identifier: Q9HCH5-11) The sequence of this isoform differs from the canonical sequence as follows: 1-487: MIDLSFLTEE...GGSSRDRQQG → MDEPNAEQVY...NAESWRNPSS 539-539: V → DEKPDQKPVTNECVPRI 571-610: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 9 (identifier: Q9HCH5-12) The sequence of this isoform differs from the canonical sequence as follows: 1-487: MIDLSFLTEE...GGSSRDRQQG → MLFPQGAHLV...NAESWRNPSS | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 10 (identifier: Q9HCH5-13) The sequence of this isoform differs from the canonical sequence as follows: 157-157: K → KQ | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 11 (identifier: Q9HCH5-14) The sequence of this isoform differs from the canonical sequence as follows: 1-48: Missing. 539-539: V → DEKPDQKPVTNECVPRI | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 12 (identifier: Q9HCH5-15) The sequence of this isoform differs from the canonical sequence as follows: 1-142: Missing. 571-610: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||
Molecule processing | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 934 | 934 | Synaptotagmin-like protein 2 | PRO_0000190213 | ||||||||||||
Regions | ||||||||||||||||
| Domain | 1 – 57 | 57 | RabBD | |||||||||||||
| Domain | 629 – 733 | 105 | C2 1 | |||||||||||||
| Domain | 778 – 880 | 103 | C2 2 | |||||||||||||
| Compositional bias | 579 – 619 | 41 | Ser-rich | |||||||||||||
Amino acid modifications | ||||||||||||||||
| Modified residue | 262 | 1 | Phosphoserine By similarity | |||||||||||||
| Modified residue | 278 | 1 | Phosphoserine By similarity | |||||||||||||
| Modified residue | 488 | 1 | Phosphoserine By similarity | |||||||||||||
| Modified residue | 562 | 1 | Phosphoserine By similarity | |||||||||||||
Natural variations | ||||||||||||||||
| Alternative sequence | 1 – 569 | 569 | Missing in isoform 7. | VSP_037896 | ||||||||||||
| Alternative sequence | 1 – 558 | 558 | Missing in isoform 2 and isoform 3. | VSP_007885 | ||||||||||||
| Alternative sequence | 1 – 487 | 487 | MIDLS…DRQQG → MDEPNAEQVYNPSQFENLRK FWDLEANSNSKDNDKNITTT SQKNSAPFNRQKHKEFSDIK LSGKNTHEAEVLLSPKKVMA REEMEKLNSKGILQVLPDEI TFPLSPLRKYTYQLPGNESS KENVEKNTEGIVTPVFKEEK DYSEQEIQESIIKTNVLSKD CKDTFNDSLQKLLSETSTPA IQPSGGKVHGKQVLEPSVSE NRTWPQKTDFADTEEEVKGP EKIINEHVDKTVVHPKVKRN SLTASLDKLLKEATGTSPSP LQAKLAPVITGTNSKLEEGR FFGKGIEQSHNTSADKREIL APFPVRDETFGNTALLKKAE SGECQLSTQNLIQMAAEDSH PLDPTSQLSRKGSFGDVASP PQDMLFPQDAHLVPQARVHP SQTEISETVEKVILPPRPVL NDVSAALQKLCGEVWLSYPA GREVGPGEVNPEFPEAVQPV CSPLNPPGVISPWATMDTIV PDRKDFYSSNVVPDKTHEVG SYLAAQMSPSDQTLSSFASI VAQYGKGLPQEVEEIVRETI VQPKSEFLEFSAGLEKLLKE ETETFPSKYESDTGNLSPSK LIGSTEEPRRATSECHPEEL KETVEKAEAPLITESAFDAG FEKLLKEITEAPPYQPQVSV REETHEKESSQSEQTRFLGT VPHFYRAASQTSEMKDKSNG LESQVNQCDKMLGGDALVTD LLVDFCGSRSGVEIPRTPQL YVAHEIGTIKTVTPPEDRDS ESGVAGGQGTLQEPGFGEAS EAISVSRNRQPIPLLMNKEN STKTSKVELTLASPYMKQEK EEEKEGFSESDFSDGNTSSN AESWRNPSS in isoform 5, isoform 6 and isoform 8. | VSP_037900 | ||||||||||||
| Alternative sequence | 1 – 487 | 487 | MIDLS…DRQQG → MLFPQGAHLVPQARVHPSQM EISETVEKVILPPRPVLNDV SAALQKLCGEVWLSYPAGRE VGPGEVNPEFPEAVQPVCSP LNPPGVISPWATMDTIVPDR KDFYSSNVVPDKTHEVGSYL AAQMSPSDQTLSSFASIVAQ YGKGLPQEVEEIVRETIVQP KSEFLEFSAGLEKLLKEETE TFPSKYESDTGNLSPSKLIG STEEPRRATSECHPEELKET VEKAEAPLITESAFDAGFEK LLKEITEAPPYQPQVSVREE THEKESSQSEQTRFLGTVPH FYRAASQTSEMKDKSNGLES QVNQCDKMLGGDALVTDLLV DFCGSRSGVEIPRTPQLYVA HEIGTIKTVTPPEDRDSESG VAGGQGTLQEPGFGEASEAI SVSRNRQPIPLLMNKENSTK TSKVELTLASPYMKQEKEEE KEGFSESDFSDGNTSSNAES WRNPSS in isoform 9. | VSP_037899 | ||||||||||||
| Alternative sequence | 1 – 142 | 142 | Missing in isoform 12. | VSP_037901 | ||||||||||||
| Alternative sequence | 1 – 48 | 48 | Missing in isoform 11. | VSP_037902 | ||||||||||||
| Alternative sequence | 157 | 1 | K → KQ in isoform 10. | VSP_037904 | ||||||||||||
| Alternative sequence | 539 | 1 | V → DEKPDQKPVTNECVPRI in isoform 4, isoform 6, isoform 8 and isoform 11. | VSP_037905 | ||||||||||||
| Alternative sequence | 570 | 1 | E → M in isoform 7. | VSP_037906 | ||||||||||||
| Alternative sequence | 571 – 610 | 40 | Missing in isoform 3, isoform 4, isoform 8 and isoform 12. | VSP_019004 | ||||||||||||
Experimental info | ||||||||||||||||
| Mutagenesis | 11 | 1 | E → A: Abolishes interaction with RAB27A. Ref.1 | |||||||||||||
| Mutagenesis | 32 | 1 | R → A: Abolishes interaction with RAB27A. Ref.1 | |||||||||||||
| Sequence conflict | 603 | 1 | S → P in ABV82746. Ref.1 | |||||||||||||
| Sequence conflict | 658 | 1 | A → V in BAD18516. Ref.4 | |||||||||||||
| Sequence conflict | 682 | 1 | K → M in AAI44116. Ref.7 | |||||||||||||
| Sequence conflict | 718 | 1 | I → V in BAB15030. Ref.4 | |||||||||||||
| Sequence conflict | 860 | 1 | A → V in BAB13423. Ref.3 | |||||||||||||
Secondary structure | ||||||||||||||||
Helix Strand Turn | ||||||||||||||||
| Helix | 10 – 35 | 26 | ||||||||||||||
| Helix | 36 – 38 | 3 | ||||||||||||||
| Helix | 43 – 49 | 7 | ||||||||||||||
| Helix | 53 – 55 | 3 | ||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates in cytotoxic granule secretion." Menasche G., Menager M.M., Lefebvre J.M., Deutsch E., Athman R., Lambert N., Mahlaoui N., Court M., Garin J., Fischer A., de Saint Basile G. Blood 112:5052-5062(2008) [PubMed: 18812475] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH RAB27A, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DOMAIN, PROTEOLYTIC PROCESSING, MUTAGENESIS OF GLU-11 AND ARG-32. |
| [2] | "SGA-72M, a breast cancer-associated antigen." Petroziello J.M., Law C.L., Wahl A.F. Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). |
| [3] | "Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O. DNA Res. 7:273-281(2000) [PubMed: 10997877] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Brain. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 7; 9; 11 AND 12), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-538 (ISOFORMS 5/6), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-462 (ISOFORMS 1 AND 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 260-934 (ISOFORM 8). Tissue: Brain, Colon, Mesenchymal stem cell, Teratocarcinoma, Thalamus, Tongue and Uterus. |
| [5] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed: 16554811] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 10). Tissue: Brain, Lung, Mammary gland and Testis. |
| [8] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 697-934. Tissue: Lymph node. |
| [9] | "Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain." Yu M., Kasai K., Nagashima K., Torii S., Yokota-Hashimoto H., Okamoto K., Takeuchi T., Gomi H., Izumi T. Mol. Biol. Cell 18:688-696(2007) [PubMed: 17182843] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORM 4), FUNCTION, DOMAIN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [10] | "Slp1 and Slp2-a localize to the plasma membrane of CTL and contribute to secretion from the immunological synapse." Holt O., Kanno E., Bossi G., Booth S., Daniele T., Santoro A., Arico M., Saegusa C., Fukuda M., Griffiths G.M. Traffic 9:446-457(2008) [PubMed: 18266782] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [11] | "Elucidation of Rab27 recruitment by its effectors: structure of Rab27a bound to Exophilin4/Slp2-a." Chavas L.M., Ihara K., Kawasaki M., Torii S., Uejima T., Kato R., Izumi T., Wakatsuki S. Structure 16:1468-1477(2008) [PubMed: 18940603] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 10-62, INTERACTION WITH RAB27A. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | EU035829 mRNA. Translation: ABV82746.1. AY386362 mRNA. Translation: AAR25619.1. Different initiation. AB046817 mRNA. Translation: BAB13423.1. Sequence problems. AK000170 mRNA. Translation: BAA90989.1. Sequence problems. AK024872 mRNA. Translation: BAB15030.1. AK074737 mRNA. Translation: BAC11170.1. AK092121 mRNA. Translation: BAG52485.1. AK124754 mRNA. Translation: BAC85937.1. AK127504 mRNA. No translation available. AK131365 mRNA. Translation: BAD18516.1. Different initiation. AK296224 mRNA. Translation: BAG58947.1. AK296740 mRNA. Translation: BAG59325.1. AK298604 mRNA. Translation: BAG60788.1. AP000642 Genomic DNA. No translation available. CH471076 Genomic DNA. Translation: EAW75110.1. BC015540 mRNA. Translation: AAH15540.2. BC110315 mRNA. Translation: AAI10316.1. BC136450 mRNA. Translation: AAI36451.1. BC144114 mRNA. Translation: AAI44115.1. BC144115 mRNA. Translation: AAI44116.1. AL834422 mRNA. Translation: CAD39083.1. | ||||||||||||
| IPI | IPI00059975. IPI00654696. IPI00783901. IPI00784324. IPI00935700. IPI00943822. IPI00943880. IPI00943912. IPI00943921. IPI00943945. IPI00975471. IPI00975473. | ||||||||||||
| RefSeq | NP_001156423.1. NM_001162951.1. NP_001156424.1. NM_001162952.1. NP_001156425.1. NM_001162953.1. NP_115755.2. NM_032379.3. NP_116561.1. NM_032943.3. NP_996810.1. NM_206927.2. NP_996811.1. NM_206928.2. NP_996812.1. NM_206929.2. NP_996813.1. NM_206930.2. | ||||||||||||
| UniGene | Hs.369520. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9HCH5. | ||||||||||||
| SMR | Q9HCH5. Positions 10-56, 626-927. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q9HCH5. 1 interaction. | ||||||||||||
| MINT | MINT-1192429. | ||||||||||||
| STRING | Q9HCH5. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9HCH5. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 257051068. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q9HCH5. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000316356; ENSP00000318803; ENSG00000137501. ENST00000359152; ENSP00000352065; ENSG00000137501. ENST00000389956; ENSP00000374606; ENSG00000137501. ENST00000389958; ENSP00000374608; ENSG00000137501. ENST00000389959; ENSP00000374609; ENSG00000137501. ENST00000436296; ENSP00000391277; ENSG00000137501. | ||||||||||||
| GeneID | 54843. | ||||||||||||
| KEGG | hsa:54843. | ||||||||||||
| UCSC | uc001pav.1. human. uc001paw.1. human. uc001pbe.1. human. uc001pbf.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 54843. | ||||||||||||
| GeneCards | GC11M085405. | ||||||||||||
| HGNC | HGNC:15585. SYTL2. | ||||||||||||
| HPA | HPA039651. | ||||||||||||
| MIM | 612880. gene. | ||||||||||||
| neXtProt | NX_Q9HCH5. | ||||||||||||
| PharmGKB | PA37985. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG09947. | ||||||||||||
| GeneTree | ENSGT00550000074462. | ||||||||||||
| HOVERGEN | HBG060218. | ||||||||||||
| OrthoDB | EOG4QC15M. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9HCH5. | ||||||||||||
| Bgee | Q9HCH5. | ||||||||||||
| CleanEx | HS_SYTL2. | ||||||||||||
| Genevestigator | Q9HCH5. | ||||||||||||
| GermOnline | ENSG00000137501. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR000008. C2_Ca-dep. IPR008973. C2_Ca/lipid-bd_dom_CaLB. IPR018029. C2_membr_targeting. IPR010911. Rab-bd_domain. IPR011011. Znf_FYVE_PHD. IPR013083. Znf_RING/FYVE/PHD. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:3.30.40.10. Znf_RING/FYVE/PHD. 1 hit. | ||||||||||||
| Pfam | PF00168. C2. 2 hits. [Graphical view] | ||||||||||||
| SMART | SM00239. C2. 2 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF49562. C2_CaLB. 2 hits. SSF57903. FYVE_PHD_ZnF. 1 hit. | ||||||||||||
| PROSITE | PS50004. C2. 2 hits. PS50916. RABBD. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 57663. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | SYTL2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9HCH5 Secondary accession number(s): B3KRS3 Q9NXM1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with